NXGN Pengajuan SEC - NextGen Healthcare Inc- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	549300N5HIPS1URF0F20
CIK	708818

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to NextGen Healthcare Inc

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

November 20, 2023	15-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-12537 NextGen Healthcare, Inc. (Exact name of registrant as specified in
November 9, 2023	EX-3.1	SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEXTGEN HEALTHCARE, INC. ARTICLE ONE Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEXTGEN HEALTHCARE, INC. ARTICLE ONE The name of the corporation is NextGen Healthcare, Inc. (the “Corporation”). ARTICLE TWO The address of the Corporation’s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such addres
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	EX-3.2	SECOND AMENDED AND RESTATED BY-LAWS NEXTGEN HEALTHCARE, INC. A Delaware corporation (Adopted as of November 9, 2023) ARTICLE I Exhibit 3.2 SECOND AMENDED AND RESTATED BY-LAWS OF NEXTGEN HEALTHCARE, INC. A Delaware corporation (Adopted as of November 9, 2023) ARTICLE I OFFICES Section 1 Registered Office. The registered office of the corporation in the State of Delaware shall be located at 1209 Orange Street, city of Wilmington, Delaware, 19801, County of New Castle. The name of the corporation’s registered agent at such a
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	S-8 POS	As filed with the Securities and Exchange Commission on November 9, 2023 As filed with the Securities and Exchange Commission on November 9, 2023 Registration No.
November 9, 2023	EX-4.1	NEXTGEN HEALTHCARE, INC. U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of November 9, 2023 3.75% Convertible Senior Notes due 2027 Exhibit 4.1 Execution Version NEXTGEN HEALTHCARE, INC. AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of November 9, 2023 3.75% Convertible Senior Notes due 2027 FIRST SUPPLEMENTAL INDENTURE, dated as of November 9, 2023 (this “Supplemental Indenture”), among NextGen Healthcare, Inc., a Delaware corporation (the “Company”), as issuer, and U.S. B
November 7, 2023	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
November 1, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 NEXTGEN HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
November 1, 2023	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
October 24, 2023	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
October 24, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
October 24, 2023	EX-99.1	NextGen Healthcare Reports Fiscal 2024 Second Quarter Results Exhibit 99.1 NextGen Healthcare Reports Fiscal 2024 Second Quarter Results REMOTE-FIRST COMPANY/NEW YORK– October 24, 2023 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal second quarter ending September 30, 2023. Fiscal 2024 Second Quarter Highlights • Total revenue was $1
October 20, 2023	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
October 20, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2023 NEXTGEN HEALTHCA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
October 10, 2023	SC 13G/A	NXGN / NextGen Healthcare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0006-nextgenhealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: NextGen Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 65343C102 Date of Event Which Requires Filing of this Statement: September 29, 2023 Check the appropriate box to
October 6, 2023	DEFM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D
September 26, 2023	PREM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ D
September 26, 2023	EX-FILING FEES	CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) NextGen Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Exhibit 107 CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) NextGen Healthcare, Inc.
September 6, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
September 6, 2023	EX-99.1	NextGen Healthcare Enters into Definitive Agreement to Be Acquired by Thoma Bravo NextGen Healthcare Shareholders to Receive $23.95 Per Share in Cash, a 46.4% Premium to Unaffected Stock Price Transaction to Accelerate NextGen Healthcare’s Growth and EX-99.1 Exhibit 99.1 NextGen Healthcare Enters into Definitive Agreement to Be Acquired by Thoma Bravo NextGen Healthcare Shareholders to Receive $23.95 Per Share in Cash, a 46.4% Premium to Unaffected Stock Price Transaction to Accelerate NextGen Healthcare’s Growth and Innovation as the Trusted Advisor to Healthcare Providers REMOTE-FIRST COMPANY/NEW YORK – September 6, 2023 – NextGen Healthcare
September 6, 2023	EX-2.1	Agreement and Plan of Merger, dated as of September 5, 2023, by and among NextGen Healthcare, Inc., Holdco, LLC, and Next Merger Sub, Inc. EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among NEXT HOLDCO, LLC, NEXT MERGER SUB, INC. and NEXTGEN HEALTHCARE, INC. Dated as of September 5, 2023 TABLE OF CONTENTS Page Article I DEFINITIONS & INTERPRETATIONS 2 1.1 Certain Definitions 2 1.2 Additional Definitions 13 1.3 Certain Interpretations 15 Article II THE MERGER 16 2.1 The Merger 16 2.2 The Effective Time 17 2.3 The Closing 17
September 6, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 NEXTGEN HEALTHC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
September 6, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
September 6, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 NEXTGEN HEALTHC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2023 NEXTGEN HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
August 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2023 NEXTGEN HEALTHCAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissio
August 23, 2023	EX-10.1	NextGen Healthcare, Inc. Amended 2015 Equity Incentive Plan, as Amended and Restated. Exhibit 10.1 NextGen Healthcare, Inc. 2015 Equity Incentive Plan Adopted by the Board of Directors: May 20, 2015 Approved by the Shareholders: August 11, 2015 Amended by the Board of Directors: June 13, 2017 Approved by the Shareholders: August 22, 2017 Amended by the Board of Directors: May 22, 2019 Approved by the Shareholders: August 15, 2019 Amended by the Board of Directors: May 25, 2021 Appr
July 27, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
July 25, 2023	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as s
July 25, 2023	EX-4.1	Amendment No. 3 to Credit Agreement, dated as of April 28, 2023, by and among NextGen Healthcare, Inc., JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto. Exhibit 4.1 EXECUTION VERSION AMENDMENT NO. 3 Dated as of April 28, 2023 to CREDIT AGREEMENT Dated as of March 12, 2021 THIS AMENDMENT NO. 3 (this “Amendment”) is made as of April 28, 2023 by and among NextGen Healthcare, Inc. (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent’), under
July 24, 2023	EX-99.1	NextGen Healthcare Reports Fiscal 2024 First Quarter Results Raises Midpoint of Fiscal 2024 Revenue Guidance Range Exhibit 99.1 NextGen Healthcare Reports Fiscal 2024 First Quarter Results Raises Midpoint of Fiscal 2024 Revenue Guidance Range REMOTE-FIRST COMPANY/NEW YORK– July 24, 2023 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ending June 30, 2023. Fiscal 2024 Firs
July 24, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 NEXTGEN HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
July 14, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2023 NEXTGEN HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
June 16, 2023	SC 13G	NXGN / NextGen Healthcare Inc / Three Prong Investments, LLC - THE SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )1 NextGen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 65343C102 (CUSIP Number) J
May 23, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specifie
May 23, 2023	EX-21	List of subsidiaries. Exhibit 21 NEXTGEN HEALTHCARE, INC. LIST OF SUBSIDIARIES Name of Subsidiary State or Other Jurisdiction of Incorporation or Organization NextGen Healthcare Information Systems, LLC California NXGN Management LLC (f/k/a QSI Management LLC) California NextGen Cares Foundation, Inc. California NextGen RCM Services, LLC Missouri TSI Healthcare, LLC Delaware NextGen Healthcare India Pvt. Ltd. India Nex
May 23, 2023	EX-4.1	Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4.1 Description of the Company’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act The following is a brief description of the capital stock of NextGen Healthcare, Inc., a Delaware corporation (the “Company,” “we,” “us,” or “our”) and is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (our “charter”),
May 16, 2023	EX-99.1	NextGen Healthcare Reports Fiscal 2023 Fourth Quarter and Full Year Results Exhibit 99.1 NextGen Healthcare Reports Fiscal 2023 Fourth Quarter and Full Year Results REMOTE-FIRST COMPANY/NEW YORK– May 16, 2023 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal fourth quarter and year ended March 31, 2023. Fiscal 2023 Fourth Quarter Highlights • Total
May 16, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 NEXTGEN HEALTHCARE, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
February 9, 2023	SC 13G/A	NXGN / Nextgen Healthcare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01519-nextgenhealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: NextGen Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 65343C102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to
February 7, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
January 25, 2023	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
January 25, 2023	EX-10.2	Securities Purchase Agreement, dated November 30, 2022, by and among NextGen Healthcare, Inc, TSI Healthcare, LLC, TSIH Holdings, Inc., a North Carolina corporation and the sole equity holder of TSI, David Dickson, Jr. and Glenn Dickson Execution Version Exhibit 10.2 SECURITIES PURCHASE AGREEMENT BY AND AMONG NEXTGEN HEALTHCARE, INC., TSI Healthcare, LLC, TSIH HOLDINGS, INC. AND David Dickson, Jr. and Glenn Dickson DATED AS OF NOVEMBER 30, 2022 Execution Version Article I PURCHASE AND SALE 1 1.1 Purchase and Sale 1 1.2 Closing 1 1.3 Purchase Price; Escrow 1 1.4 Payment of Purchase Price; Transfer of Units. 2 1.5 Working Capital A
January 24, 2023	EX-99.1	NextGen Healthcare Reports Fiscal 2023 Third Quarter Results Raises Full Year Revenue Guidance and Reaffirms Earnings Exhibit 99.1 NextGen Healthcare Reports Fiscal 2023 Third Quarter Results Raises Full Year Revenue Guidance and Reaffirms Earnings REMOTE-FIRST COMPANY/NEW YORK –January 24, 2023 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal third quarter ended December 31, 2022. Fiscal
January 24, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2023 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
December 5, 2022	EX-99.1	NextGen Healthcare Announces Agreement to Acquire TSI Healthcare Exhibit 99.1 NextGen Healthcare Announces Agreement to Acquire TSI Healthcare REMOTE-FIRST COMPANY/CHAPEL HILL, NC ?Nov. 30, 2022 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative cloud-based healthcare technology solutions, today announced it has signed a definitive agreement to acquire TSI Healthcare, a privately held value-added reseller located in Chapel Hill, NC. The
December 5, 2022	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commiss
November 1, 2022	EX-4.1	Indenture, dated as of November 1, 2022, between NextGen Healthcare, Inc. and U.S. Bank Trust Company, National Association, as trustee. Exhibit 4.1 EXECUTION VERSION NextGen Healthcare, Inc. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee ????????????????????? INDENTURE Dated as of November 1, 2022 ????????????????????? 3.75% Convertible Senior Notes due 2027 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction1 Section 1.01. Definitions.1 Section 1.02. Other Definitions.13 Section 1.03. Rules of Const
November 1, 2022	EX-10.1	Amendment No. 2 to Credit Agreement, dated as of October 27, 2022, by and among NextGen Healthcare, Inc., JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto. Exhibit 10.1 EXECUTION COPY AMENDMENT NO. 2 Dated as of October 27, 2022 to CREDIT AGREEMENT Dated as of March 12, 2021 THIS AMENDMENT NO. 2 (this ?Amendment?) is made as of October 27, 2022 by and among NextGen Healthcare, Inc. (the ?Borrower?), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the ?Administrative Agent?), unde
November 1, 2022	EX-99.1	NextGen Healthcare Announces Proposed Convertible Senior Notes Offering Exhibit 99.1 NextGen Healthcare Announces Proposed Convertible Senior Notes Offering REMOTE-FIRST COMPANY/NEW YORK?(BUSINESS WIRE)?Oct. 27, 2022?NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its intention to offer, subject to market and other conditions, $200,000,000 aggregate principal amount of convertible
November 1, 2022	EX-99.2	NextGen Healthcare Prices Upsized $230.0 Million Convertible Senior Notes Offering Exhibit 99.2 NextGen Healthcare Prices Upsized $230.0 Million Convertible Senior Notes Offering REMOTE-FIRST COMPANY/NEW YORK?(BUSINESS WIRE)?Oct. 28, 2022?NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced the pricing of its offering of $230,000,000 aggregate principal amount of 3.75% convertible senior notes due
November 1, 2022	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
October 25, 2022	EX-10.1	NextGen Healthcare Director Compensation Plan (As Amended and Restated Effective August 17, 2022) Exhibit 10.1 NextGen Healthcare Director Compensation Plan (As Amended and Restated Effective August 17, 2022) Non-employee members of the board of directors (the “Board”) of NextGen Healthcare, Inc. (the “Company”) shall receive cash and equity compensation as set forth in this Director Compensation Plan (this “Plan”). The cash and equity compensation described in this Plan shall be paid or be ma
October 25, 2022	EX-10.3	NextGen Healthcare Form of Indemnification Agreement (Effective October 13, 2021) eXHIBIT 10.3 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of by and between NextGen Healthcare, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement. RECITALS WHEREAS, the Board of Directors of the
October 25, 2022	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
October 25, 2022	EX-99.1	NextGen Healthcare Reports Fiscal 2023 Second Quarter Results Raises Fiscal 2023 Financial Guidance Exhibit 99.1 NextGen Healthcare Reports Fiscal 2023 Second Quarter Results Raises Fiscal 2023 Financial Guidance REMOTE-FIRST COMPANY/NEW YORK – October 25, 2022 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal second quarter ended September 30, 2022. Fiscal 2023 Second Qua
October 25, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
October 25, 2022	EX-10.2	NextGen Healthcare Deferred Compensation Plan for Non-Employee Directors EXHIBIT 10.2 NEXTGEN HEALTHCARE, INC. DEFERRED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS 1.Purpose and Effective Date. The purpose of this Plan is to provide the non-employee members of the Board of Directors (the “Board”) of NextGen Healthcare, Inc., a Delaware corporation, and its successors (the “Company”) with an opportunity to defer payment of all or a portion of their annual restricted st
August 18, 2022	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissio
August 5, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
July 27, 2022	EX-10.1	Amendment No. 1 to Credit Agreement, dated as of May 17, 2022, by and among NextGen Healthcare, Inc., JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto. Exhibit 10.1 EXECUTION COPY AMENDMENT NO. 1 Dated as of May 17, 2022 to CREDIT AGREEMENT Dated as of March 12, 2021 THIS AMENDMENT NO. 1 (this ?Amendment?) is made as of May 17, 2022 by and among NextGen Healthcare, Inc. (the ?Borrower?), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the ?Administrative Agent?), under that c
July 27, 2022	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as s
July 26, 2022	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
July 26, 2022	EX-3.1	Second Amended and Restated Bylaws of NextGen Healthcare, Inc., dated as of July 26, 2022 Exhibit 3.1 Second Amended and Restated Bylaws of NextGen Healthcare, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office1 1.2 Other Offices1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings1 2.2 Annual Meetings1 2.3 Special Meetings1 2.4 Notice of Business to be Brought before a Meeting5 2.5 Notice of Nominations for Election to
July 26, 2022	EX-99.1	NextGen Healthcare Reports Fiscal 2023 First Quarter Results Exhibit 99.1 NextGen Healthcare Reports Fiscal 2023 First Quarter Results ATLANTA ? July 26, 2022 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal first quarter ended June 30, 2022. Fiscal 2023 First Quarter Highlights ? Total revenue was $153.3 million compared to $146.1 m
July 15, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEF 14A 1 d374725ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as
May 20, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
May 18, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specifie
May 18, 2022	EX-21	List of subsidiaries. Exhibit 21 NEXTGEN HEALTHCARE, INC. LIST OF SUBSIDIARIES Name of Subsidiary State or Other Jurisdiction of Incorporation or Organization NextGen Healthcare Information Systems, LLC California NXGN Management LLC (f/k/a QSI Management LLC) California NextGen Cares Foundation, Inc. California NextGen RCM Services, LLC Missouri NextGen Healthcare India Pvt. Ltd. India NextGen Interoperability Solutio
May 18, 2022	EX-4.1	Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Exhibit 4.1 Description of Capital Stock The following is a brief description of the capital stock of NextGen Healthcare, Inc., a Delaware corporation (the ?Company,? ?we,? ?us,? or ?our?) and is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (our ?charter?) and our Amended and Restated Bylaws (our ?bylaws?), each of which is incorpor
May 17, 2022	EX-99.1	NextGen Healthcare Reports Fiscal 2022 Fourth Quarter and Full Year Results Achieves Record Bookings in the Fiscal 2022 Fourth Quarter Exhibit 99.1 NextGen Healthcare Reports Fiscal 2022 Fourth Quarter and Full Year Results Achieves Record Bookings in the Fiscal 2022 Fourth Quarter ATLANTA ? May 17, 2022 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal fourth quarter and year ended March 31, 2022. Fiscal 2
May 17, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission F
May 2, 2022	EX-99.1	NextGen Healthcare Announces Preliminary Unaudited Fiscal 2022 Q4 and Full Year Results and Introduces Fiscal 2023 Financial Guidance Exhibit 99.1 NextGen Healthcare Announces Preliminary Unaudited Fiscal 2022 Q4 and Full Year Results and Introduces Fiscal 2023 Financial Guidance ATLANTA?May 2, 2022 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced preliminary unaudited fiscal 2022 fourth quarter and year ended March 31, 2022 results and intr
May 2, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission Fi
February 10, 2022	SC 13G/A	NXGN / Nextgen Healthcare Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: NextGen Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 65343C102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is file
January 26, 2022	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
January 25, 2022	EX-99.1	NextGen Healthcare Reports Fiscal 2022 Third Quarter Results Raises Fiscal 2022 Financial Guidance EX-99.1 2 nxgn-ex9916.htm EX-99.1 Exhibit 99.1 NextGen Healthcare Reports Fiscal 2022 Third Quarter Results Raises Fiscal 2022 Financial Guidance ATLANTA — Jan. 25, 2022 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal third quarter ended December 31, 2021. Fiscal 2022 Third Quarter Highli
January 25, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2022 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
January 10, 2022	SC 13G/A	NXGN / Nextgen Healthcare Inc / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 13)* Nextgen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 65343C102 (CUSIP Number) Eddie C. Brown Brown Capi
November 10, 2021	SC 13G/A	NXGN / Nextgen Healthcare Inc / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 12)* Nextgen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 65343C102 (CUSIP Number) Eddie C. Brown Brown Capi
October 29, 2021	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
October 29, 2021	S-8	As filed with the Securities and Exchange Commission on October 29, 2021 As filed with the Securities and Exchange Commission on October 29, 2021 Registration No.
October 29, 2021	EX-10.5	Employment Agreement, dated as of September 18, 2021, between David Sides and NextGen Healthcare, Inc. EXECUTION COPY Exhibit 10.5 Employment Agreement This Employment Agreement (this ?Agreement?) is dated as of September 18, 2021, and is made by and between NextGen Healthcare, Inc., a California corporation (together with any successor thereto, the ?Company?), and David Sides (?Executive?) (collectively referred to herein as the ?Parties? or individually referred to as a ?Party?). RECITALS A. It i
October 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
October 28, 2021	EX-99.1	NextGen Healthcare Reports Fiscal 2022 Second Quarter Results Raises Fiscal 2022 Financial Guidance Exhibit 99.1 NextGen Healthcare Reports Fiscal 2022 Second Quarter Results Raises Fiscal 2022 Financial Guidance ATLANTA ? Oct. 28, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal second quarter ended September 30, 2021. Fiscal 2022 Second Quarter Highlights ? Total revenue for the f
October 19, 2021	S-8 POS	As filed with the Securities and Exchange Commission on October 19, 2021 As filed with the Securities and Exchange Commission on October 19, 2021 Registration No.
October 19, 2021	EX-3.2	Bylaws of NextGen Healthcare, Inc., a Delaware corporation. Exhibit 3.2 Amended and Restated Bylaws of NextGen Healthcare, Inc. (a Delaware corporation) Table of Contents Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meetings 1 2.3 Special Meetings 1 2.4 Notice of Business to be Brought before a Meeting 5 2.5 Notice of Nominations for Election to t
October 19, 2021	EX-10.1	NextGen Healthcare, Inc. Amended and Restated 2015 Equity Incentive Plan. Exhibit 10.1 NEXTGEN HEALTHCARE, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MAY 20, 2015 APPROVED BY THE SHAREHOLDERS: AUGUST 11, 2015 AMENDED BY THE BOARD OF DIRECTORS: JUNE 13, 2017 APPROVED BY THE SHAREHOLDERS: AUGUST 22, 2017 AMENDED BY THE BOARD OF DIRECTORS: MAY 22, 2019 APPROVED BY THE SHAREHOLDERS: AUGUST 15, 2019 AMENDED BY THE BOARD OF DIRECTORS: MAY 25, 2021 APPR
October 19, 2021	S-8 POS	As filed with the Securities and Exchange Commission on October 19, 2021 As filed with the Securities and Exchange Commission on October 19, 2021 Registration No.
October 19, 2021	S-8 POS	As filed with the Securities and Exchange Commission on October 19, 2021 As filed with the Securities and Exchange Commission on October 19, 2021 Registration No.
October 19, 2021	EX-4.1	Form of Certificate for Shares of Common Stock of NextGen Healthcare, Inc., a Delaware corporation. Exhibit 4.1 [Specimen NextGen Healthcare, Inc. Common Stock Certificate] NUMBER SHARES NEXTGEN HEALTHCARE, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE This Certifies that is the registered holder of Shares of the Common Stock of NextGen Healthcare, Inc., par value $0.01 per share, transferable only on the books of the Corporation by the holder hereof in person or by Attorney upon sur
October 19, 2021	EX-2.1	Agreement and Plan of Merger, dated October 13, 2021, by and between NextGen Healthcare, Inc., a California corporation, and NextGen Healthcare, Inc., a Delaware corporation. Exhibit 2.1 AGREEMENT AND PLAN OF MERGER OF NEXTGEN HEALTHCARE, INC., A DELAWARE CORPORATION, AND NEXTGEN HEALTHCARE, INC. A CALIFORNIA CORPORATION This AGREEMENT AND PLAN OF MERGER, dated as of October 13, 2021 (the Agreement?), is between NextGen Healthcare, Inc., a California corporation (?Parent?), and NextGen Healthcare, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (?Del
October 19, 2021	S-8 POS	As filed with the Securities and Exchange Commission on October 19, 2021 As filed with the Securities and Exchange Commission on October 19, 2021 Registration No.
October 19, 2021	8-A12B/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-A/A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 NEXTGEN HEALTHCARE, INC. (Exact name of regis UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-A/A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 95-2888568 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification
October 19, 2021	S-8 POS	As filed with the Securities and Exchange Commission on October 19, 2021 As filed with the Securities and Exchange Commission on October 19, 2021 Registration No.
October 19, 2021	S-8 POS	As filed with the Securities and Exchange Commission on October 19, 2021 As filed with the Securities and Exchange Commission on October 19, 2021 Registration No.
October 19, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2021 Commission file number 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specified in charter) California 95-2888568 (State or other jurisdiction of inc
October 19, 2021	EX-3.1	Certificate of Incorporation of NextGen Healthcare, Inc., a Delaware corporation. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEXTGEN HEALTHCARE, INC. NextGen Healthcare, Inc. (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1. The name of the Corporation is NextGen Healthcare, Inc. The Corporation was incorporated under its current name by the
October 19, 2021	EX-99.1	NextGen Healthcare Announces 2021 Annual Meeting Results Shareholders Approve the Company’s Reincorporation into Delaware and the Elimination of Cumulative Voting in the Election of Directors Shareholders Elect All Nine of NextGen Healthcare’s Direct EX-99.1 Exhibit 99.1 NextGen Healthcare Announces 2021 Annual Meeting Results Shareholders Approve the Company’s Reincorporation into Delaware and the Elimination of Cumulative Voting in the Election of Directors Shareholders Elect All Nine of NextGen Healthcare’s Director Nominees ATLANTA – October 13, 2021 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused techno
October 14, 2021	SC 13D/A	NXGN / Nextgen Healthcare Inc / RAZIN SHELDON - AMENDMENT NO. 3 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. 3)1 NextGen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 65343C102 (CUSIP Number) SHELDON RAZIN
October 8, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
October 8, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
October 6, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
October 5, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
October 4, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
October 1, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 30, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 29, 2021	DFAN14A	REBUTTAL PRESENTATION
September 29, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 28, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 27, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 27, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 24, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 23, 2021	DFAN14A	INVESTOR PRESENTATION, DATED SEPTEMBER 23, 2021
September 23, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 23, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 21, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 21, 2021	S-8	As filed with the Securities and Exchange Commission on September 20, 2021 As filed with the Securities and Exchange Commission on September 20, 2021 Registration No.
September 21, 2021	EX-10.1	NextGen Healthcare, Inc. 2021 Employment Inducement Equity Incentive Plan Exhibit 10.1 NEXTGEN HEALTHCARE, INC. 2021 EMPLOYMENT INDUCEMENT EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: SEPTEMBER 18, 2021 1. GENERAL. (a) Eligible Award Recipients. Eligible Individuals are eligible to receive Awards. (b) Available Awards. The Plan provides for the grant of the following types of Awards: (i) Nonstatutory Stock Options, (ii) Stock Appreciation Rights (iii) Restri
September 21, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 21, 2021	EX-10.2	Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement pursuant to the NextGen Healthcare, Inc. 2021 Employment Inducement Equity Incentive Plan Exhibit 10.2 Form: Stock Award ? Employee NEXTGEN HEALTHCARE, INC. RESTRICTED STOCK AWARD GRANT NOTICE 2021 Employment Inducement Equity Incentive Plan NextGen Healthcare, Inc. (the ?Company?), pursuant to its 2021 Employment Inducement Equity Incentive Plan (the ?Plan?), hereby grants to Participant the right to receive the number of shares of the Company?s Common Stock set forth below (?Award?).
September 21, 2021	EX-10.3	Form of Performance Share Unit Award Grant Notice and Performance Share Unit Award Agreement pursuant to the NextGen Healthcare, Inc. 2021 Employment Inducement Equity Incentive Plan Exhibit 10.3 NEXTGEN HEALTHCARE, INC. PERFORMANCE STOCK AWARD GRANT NOTICE NextGen Healthcare, Inc. 2021 Employment Inducement Equity Incentive Plan NextGen Healthcare, Inc. (the ?Company?), pursuant to its 2021 Employment Inducement Equity Incentive Plan, as may be amended from time to time (the ?Plan?), hereby grants to Participant the right to receive the Performance Stock Award set forth below
September 20, 2021	EX-99.3	Letter to Employees, dated September 20, 2021 Exhibit 99.3 To: ALL NextGen Healthcare Employees From: Jeff Margolis Subject Line: Introducing Our New CEO, David Sides Dear Team, I am delighted to announce that David Sides has been appointed as NextGen Healthcare?s President and Chief Executive Officer, effective September 22. David joins us from Teladoc Health, where he most recently served as Chief Operating Officer. David brings more than t
September 20, 2021	EX-99.3	ALL NextGen Healthcare Employees Exhibit 99.3 To: ALL NextGen Healthcare Employees From: Jeff Margolis Subject Line: Introducing Our New CEO, David Sides Dear Team, I am delighted to announce that David Sides has been appointed as NextGen Healthcare?s President and Chief Executive Officer, effective September 22. David joins us from Teladoc Health, where he most recently served as Chief Operating Officer. David brings more than t
September 20, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2021 Commission file number 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specified in charter) California 95-2888568 (State or other jurisdiction of i
September 20, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 20, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Under Rule 14a-12 NEXTGEN HEALTHCARE, INC.
September 20, 2021	EX-99.2	NextGen Healthcare Reports Granting of Inducement Awards EX-99.2 3 d233324dex992.htm EX-99.2 Exhibit 99.2 NextGen Healthcare Reports Granting of Inducement Awards ATLANTA – (BUSINESS WIRE) – Sept. 20, 2021 — NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today stated that the Compensation Committee of the Company’s Board of Directors has approved the grant of inducement awards to David Sides, in c
September 20, 2021	EX-99.2	Press Release, dated September 20, 2021. Exhibit 99.2 NextGen Healthcare Reports Granting of Inducement Awards ATLANTA ? (BUSINESS WIRE) ? Sept. 20, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today stated that the Compensation Committee of the Company?s Board of Directors has approved the grant of inducement awards to David Sides, in connection with his appointment as th
September 20, 2021	EX-99.1	Press Release, dated September 20, 2021. Exhibit 99.1 NextGen Healthcare Appoints David Sides President and Chief Executive Officer Sides Brings Extensive Experience in Healthcare Software and Technology, and Proven Record Growing, Scaling and Diversifying Premier Global Healthcare Companies Appointment Builds on Strong Executive Team and Talented Employee Base Sides Joins NextGen Healthcare Director Slate for Upcoming Annual Meeting ATL
September 20, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2021 Commission fil UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2021 Commission file number 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specified in charter) California 95-2888568 (State or other jurisdiction of i
September 20, 2021	EX-99.1	NextGen Healthcare Appoints David Sides President and Chief Executive Officer Sides Brings Extensive Experience in Healthcare Software and Technology, and Proven Record Growing, Scaling and Diversifying Premier Global Healthcare Companies Appointment Exhibit 99.1 NextGen Healthcare Appoints David Sides President and Chief Executive Officer Sides Brings Extensive Experience in Healthcare Software and Technology, and Proven Record Growing, Scaling and Diversifying Premier Global Healthcare Companies Appointment Builds on Strong Executive Team and Talented Employee Base Sides Joins NextGen Healthcare Director Slate for Upcoming Annual Meeting ATL
September 16, 2021	EX-99.2	AMENDED AND RESTATED JOINT FILING AND SOLICITATION AGREEMENT Exhibit 99.2 AMENDED AND RESTATED JOINT FILING AND SOLICITATION AGREEMENT WHEREAS, certain of the undersigned are shareholders, direct or beneficial, of NextGen Healthcare Inc., a California corporation (the ?Company?); WHEREAS, Sheldon Razin (?Razin?) and Kenneth H. Fearn, Jr., Lance Rosenzweig, and Ruby Sharma (collectively, the ?Nominees?) wish to form a group for the purpose of seeking represe
September 16, 2021	EX-99.1	The Razin Group Files Definitive Proxy Statement and Sends Letter to NextGen Healthcare Shareholders Highlights the Company’s Prolonged Underperformance and Stagnation During the Six-Year Chairmanship of Jeffrey Margolis Notes That Misaligned Directo Exhibit 99.1 The Razin Group Files Definitive Proxy Statement and Sends Letter to NextGen Healthcare Shareholders Highlights the Company?s Prolonged Underperformance and Stagnation During the Six-Year Chairmanship of Jeffrey Margolis Notes That Misaligned Directors and Underperforming Executives Have Enjoyed Excessive Compensation While Shareholders Have Endured Dismal Results Urges Shareholders t
September 16, 2021	SC 13D/A	NXGN / Nextgen Healthcare Inc / RAZIN SHELDON - AMENDMENT NO. 2 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 2)1 NextGen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 65343C102 (CUSIP Number) SHELDON RAZIN
September 14, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 14, 2021	DEFC14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 13, 2021	DEFC14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definiti
September 13, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
September 10, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commi
September 9, 2021	CORRESP	[WLRK Letterhead] CORRESP 1 filename1.htm [WLRK Letterhead] September 8, 2021 Office of Mergers & Acquisitions Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Attention: Mr. Dan Duchovny Re: NextGen Healthcare, Inc. Revised Preliminary Proxy Statement (Amendment No. 1) Filed August 31, 2021 File No. 001-12537 Dear Mr. Duchovny: On behalf of our clien
September 9, 2021	PRRN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. 2) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid
September 7, 2021	SC 13D/A	NXGN / Nextgen Healthcare Inc / RAZIN SHELDON - AMENDMENT NO. 1 TO THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 NextGen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 65343C102 (CUSIP Number) SHELDON RAZIN
September 7, 2021	EX-99.1	The Razin Group Files Revised Preliminary Proxy Statement in Connection with NextGen Healthcare’s 2021 Annual Meeting Demonstrates the Razin Campaign is Not About “Boardroom Control” by Proactively Modifying Slate to Include Only Four Highly-Qualifie Exhibit 99.1 The Razin Group Files Revised Preliminary Proxy Statement in Connection with NextGen Healthcare?s 2021 Annual Meeting Demonstrates the Razin Campaign is Not About ?Boardroom Control? by Proactively Modifying Slate to Include Only Four Highly-Qualified Director Candidates Looks to Replace Four Entrenched Directors, Including Imperial Chairman Jeffrey Margolis, Who Have Presided Over th
September 2, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
September 2, 2021	PRRN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confid
August 31, 2021	PRER14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Amendment No. 1) SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Amendment No. 1) SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6
August 27, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
August 27, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
August 26, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
August 26, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide
August 25, 2021	EX-99.1	Two NextGen Healthcare Directors Nominate Four Additional Candidates for Election to the Board at 2021 Annual Meeting Founder and Director Sheldon Razin and Director Lance Rosenzweig Issue Open Letter to Fellow Shareholders Regarding the Need to Furt Exhibit 99.1 Two NextGen Healthcare Directors Nominate Four Additional Candidates for Election to the Board at 2021 Annual Meeting Founder and Director Sheldon Razin and Director Lance Rosenzweig Issue Open Letter to Fellow Shareholders Regarding the Need to Further Refresh and Reinvigorate the Board Cite Serious Concerns Regarding Imperial Chairman Jeffrey Margolis, who has Presided Over Insular
August 25, 2021	SC 13D	NXGN / Nextgen Healthcare Inc / RAZIN SHELDON - THE SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO ? 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO ? 240.13d-2(a) (Amendment No. )1 NextGen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 65343C102 (CUSIP Number) SHELDON RAZIN
August 25, 2021	PREC14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confide
August 25, 2021	EX-99.2	JOINT FILING AND SOLICITATION AGREEMENT Exhibit 99.2 JOINT FILING AND SOLICITATION AGREEMENT WHEREAS, certain of the undersigned are shareholders, direct or beneficial, of NextGen Healthcare Inc., a California corporation (the ?Company?); WHEREAS, Sheldon Razin and Kenneth H. Fearn, Jr., Ramon Gregory, Lance Rosenzweig, Julie Schoenfeld and Ruby Sharma (collectively, the ?Nominees?) wish to form a group for the purpose of seeking repres
August 25, 2021	EX-99.3	POWER OF ATTORNEY EX-99.3 4 ex993to13d1307900208242021.htm FORM OF POWER OF ATTORNEY Exhibit 99.3 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints Sheldon Razin the undersigned’s true and lawful attorney-in-fact to take any and all action in connection with (i) the undersigned’s beneficial ownership of, or participation in a group with respect to, securities of Next
August 23, 2021	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definiti
August 23, 2021	PREC14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definiti
August 23, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
August 20, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement
August 20, 2021	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Ame UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of The Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide
August 18, 2021	EX-99.1	NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthc Exhibit 99.1 NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthcare Industry and Advance Board Diversity ATLANTA?August 17, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulat
August 18, 2021	EX-99.2	Press Release dated August 11, 2021 Exhibit 99.2 NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders ATLANTA?August 11, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will hold its 2021 Annual Meeting of Shareholders on October 13, 2021 at 10:00 a.m. Eastern. The meeting will be held at NextGen Healthcare?s corporate headquarters located at 3525 Pi
August 18, 2021	EX-99.2	Press Release dated August 11, 2021 Exhibit 99.2 NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders ATLANTA?August 11, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will hold its 2021 Annual Meeting of Shareholders on October 13, 2021 at 10:00 a.m. Eastern. The meeting will be held at NextGen Healthcare?s corporate headquarters located at 3525 Pi
August 18, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 NEXTGEN HEALTHCAR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commiss
August 18, 2021	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Inc
August 18, 2021	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Shareholder Director Nominations UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Inc
August 18, 2021	EX-3.1	Fourth Amended and Restated Bylaws of the Registrant EXHIBIT 3.1 FOURTH AMENDED AND RESTATED BYLAWS for the regulation, except as otherwise provided by statute or the Articles of Incorporation, of NEXTGEN HEALTHCARE, INC. (a California corporation) ARTICLE I OFFICES Section 1. PRINCIPAL EXECUTIVE OFFICE. The Board of Directors (herein called the ?Board?) shall fix the location of the principal executive office of the corporation at any place within
August 18, 2021	EX-99.2	NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders Exhibit 99.2 NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders ATLANTA?August 11, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will hold its 2021 Annual Meeting of Shareholders on October 13, 2021 at 10:00 a.m. Eastern. The meeting will be held at NextGen Healthcare?s corporate headquarters located at 3525 Pi
August 18, 2021	EX-99.1	Press Release dated August 17, 2021 Exhibit 99.1 NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthcare Industry and Advance Board Diversity ATLANTA?August 17, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulat
August 18, 2021	EX-3.1	Fourth Amended and Restated Bylaws EXHIBIT 3.1 FOURTH AMENDED AND RESTATED BYLAWS for the regulation, except as otherwise provided by statute or the Articles of Incorporation, of NEXTGEN HEALTHCARE, INC. (a California corporation) ARTICLE I OFFICES Section 1. PRINCIPAL EXECUTIVE OFFICE. The Board of Directors (herein called the ?Board?) shall fix the location of the principal executive office of the corporation at any place within
August 18, 2021	EX-3.1	Fourth Amended and Restated Bylaws EXHIBIT 3.1 FOURTH AMENDED AND RESTATED BYLAWS for the regulation, except as otherwise provided by statute or the Articles of Incorporation, of NEXTGEN HEALTHCARE, INC. (a California corporation) ARTICLE I OFFICES Section 1. PRINCIPAL EXECUTIVE OFFICE. The Board of Directors (herein called the ?Board?) shall fix the location of the principal executive office of the corporation at any place within
August 18, 2021	EX-99.1	Press Release dated August 17, 2021 Exhibit 99.1 NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthcare Industry and Advance Board Diversity ATLANTA?August 17, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulat
August 17, 2021	EX-99.2	NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders Exhibit 99.2 NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders ATLANTA?August 11, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will hold its 2021 Annual Meeting of Shareholders on October 13, 2021 at 10:00 a.m. Eastern. The meeting will be held at NextGen Healthcare?s corporate headquarters located at 3525 Pi
August 17, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Shareholder Director Nominations UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commiss
August 17, 2021	EX-3.1	Fourth Amended and Restated Bylaws EXHIBIT 3.1 FOURTH AMENDED AND RESTATED BYLAWS for the regulation, except as otherwise provided by statute or the Articles of Incorporation, of NEXTGEN HEALTHCARE, INC. (a California corporation) ARTICLE I OFFICES Section 1. PRINCIPAL EXECUTIVE OFFICE. The Board of Directors (herein called the ?Board?) shall fix the location of the principal executive office of the corporation at any place within
August 17, 2021	EX-99.1	NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthc Exhibit 99.1 NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board Dr. Geraldine McGinty and Dr. Pamela S. Puryear Bring Substantial Experience in Strategy, Operations and Talent in the Healthcare Industry and Advance Board Diversity ATLANTA?August 17, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulat
July 30, 2021	10-Q	UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as s
July 29, 2021	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of re
July 29, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissio
July 29, 2021	EX-10.37	Separation Agreement, dated as of June 19, 2021, by and between NextGen Healthcare, Inc. and John R. Frantz Exhibit 10.37 RELEASE OF CLAIMS This release of claims (this ?Agreement?) is made by and between NextGen Healthcare, Inc. (the ?Company?), and John R. Frantz (?Executive?). The Company and Executive are sometimes collectively referred to herein as the ?Parties? and individually referred to as a ?Party.? RECITALS WHEREAS, Executive signed a Proprietary Information and Inventions Agreement (the ?Con
July 29, 2021	EX-99.1	NextGen Healthcare Reports Fiscal 2022 First Quarter Results Raises Fiscal 2022 Revenue Guidance Exhibit 99.1 NextGen Healthcare Reports Fiscal 2022 First Quarter Results Raises Fiscal 2022 Revenue Guidance ATLANTA ? July 29, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal first quarter ended June 30, 2021. Fiscal 2022 First Quarter Highlights ? Total revenue for the fiscal 2022
July 29, 2021	EX-10.38	Form of Performance Stock Award Grant Notice and Performance Stock Award Agreement for 2015 Equity Incentive Plan, as amended Exhibit 10.38 NextGen Healthcare, Inc. Performance Stock Award Grant Notice NextGen Healthcare, Inc. 2015 Equity Incentive Plan NextGen Healthcare, Inc. (the ?Company?), pursuant to its 2015 Equity Incentive Plan (formerly known as the Quality Systems, Inc. 2015 Equity Incentive Plan), as may be amended from time to time (the ?Plan?), hereby grants to Participant the right to receive the Performan
June 21, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) CALIFORNIA 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissio
June 21, 2021	EX-99.1	NextGen Healthcare Announces CEO Transition Board of Directors Establishes Executive Leadership and Board Oversight Committees and Commences CEO Search Company Affirms Fiscal Year 2022 Financial Outlook Exhibit 99.1 NextGen Healthcare Announces CEO Transition Board of Directors Establishes Executive Leadership and Board Oversight Committees and Commences CEO Search Company Affirms Fiscal Year 2022 Financial Outlook ATLANTA ? June 21, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that the Company and Rusty Frantz have
June 21, 2021	EX-3.1	Third Amended and Restated Bylaws of NextGen Healthcare, Inc., effective June 18, 2021. Exhibit 3.1 THIRD AMENDED AND RESTATED BYLAWS for the regulation, except as otherwise provided by statute or the Articles of Incorporation, of NEXTGEN HEALTHCARE, INC. (a California corporation) ARTICLE I OFFICES Section 1. PRINCIPAL EXECUTIVE OFFICE. The Board of Directors (herein called the ?Board?) shall fix the location of the principal executive office of the corporation at any place within o
May 27, 2021	EX-4.1	Description of Registrant’s Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 EXHIBIT 4.1 DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 General The articles of incorporation, as amended, of NextGen Healthcare, Inc. ("NextGen") authorize the issuance of up to 100,000,000 shares of common stock, $0.01 par value per share. As of March 31, 2021, there were 67,068,810 shares of common stock issued and outstand
May 27, 2021	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specifie
May 27, 2021	EX-21	List of subsidiaries. EX-21 3 nxgn-ex217.htm EX-21 Exhibit 21 NEXTGEN HEALTHCARE, INC. LIST OF SUBSIDIARIES Name of Subsidiary State or Other Jurisdiction of Incorporation or Organization NextGen Healthcare Information Systems, LLC California NXGN Management LLC (f/k/a QSI Management LLC) California NextGen Cares Foundation, Inc. California NextGen RCM Services, LLC Missouri Topaz Information Systems, LLC Arizona Medfu
May 26, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
May 26, 2021	EX-99.1	NextGen Healthcare Reports Fiscal 2021 Fourth Quarter and Full Year Results Exhibit 99.1 NextGen Healthcare Reports Fiscal 2021 Fourth Quarter and Full Year Results ATLANTA ? May 26, 2021 ? NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal fourth quarter and full year 2021 ended March 31, 2021. Fiscal 2021 Fourth Quarter and Full Year Highlights ? Total revenue for t
March 16, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissi
March 16, 2021	EX-99.1	NextGen Healthcare Announces Update to Credit Facility EX-99.1 3 nxgn-ex9916.htm EX-99.1 Exhibit 99.1 NextGen Healthcare Announces Update to Credit Facility ATLANTA — March 16, 2021 – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that on March 12, 2021, it entered into a $300 million second amended and restated revolving credit agreement with JPMorgan Chase Bank, N.A., as admini
March 16, 2021	EX-10.1	Second Amended and Restated Credit Agreement, dated as of March 12, 2021, among NextGen, Inc., JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank National Association and Bank of the West, as co-syndication agents, and certain other agents and lenders Exhibit 10.1 EXECUTION COPY SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 12, 2021 among NEXTGEN HEALTHCARE, Inc. The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent U.S. BANK NATIONAL ASSOCIATION and BANK OF THE WEST as Co-Syndication Agents and WELLS FARGO BANK, NATIONAL ASSOCIATION, CITY NATIONAL BANK, TRUIST BANK and BBVA USA as Co-Documentation Agents J
February 12, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 11)* Nex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 11)* Nextgen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 65343C102 (CUSIP Number) Eddie C. Brown Brown Capi
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: NextGen Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 65343C102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is file
January 28, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
January 27, 2021	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
January 27, 2021	EX-99.1	NextGen Healthcare, Inc. Reports Fiscal 2021 Third Quarter Results Exhibit 99.1 NextGen Healthcare, Inc. Reports Fiscal 2021 Third Quarter Results IRVINE, Calif. — Jan. 27, 2021— NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, today announced its fiscal 2021 third quarter ended December 31, 2020 operating results. Fiscal Third Quarter 2021 Highlights On a GAAP basis, revenue for the fiscal 2021 th
January 27, 2021	EX-3.1	Second Amended and Restated Bylaws of NextGen Healthcare, Inc., effective January 26, 2021 Exhibit 3.1 SECOND AMENDED AND RESTATED BYLAWS for the regulation, except as otherwise provided by statute or the Articles of Incorporation, of NEXTGEN HEALTHCARE, INC. (a California corporation) ARTICLE I OFFICES Section 1. PRINCIPAL EXECUTIVE OFFICE. The Board of Directors (herein called the “Board”) shall fix the location of the principal executive office of the corporation at any place within
January 13, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2021 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
January 13, 2021	EX-99.1	NextGen Healthcare, Inc. Announces Preliminary Unaudited Fiscal 2021 Q3 Results and Raises Fiscal 2021 Financial Guidance Company to Announce Final Fiscal 2021 Third Quarter Results and Host Conference Call on Jan. 27, 2021 Exhibit 99.1 NextGen Healthcare, Inc. Announces Preliminary Unaudited Fiscal 2021 Q3 Results and Raises Fiscal 2021 Financial Guidance Company to Announce Final Fiscal 2021 Third Quarter Results and Host Conference Call on Jan. 27, 2021 IRVINE, Calif. — Jan. 13, 2021— NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, today announced
October 28, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
October 23, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
October 22, 2020	EX-99.1	NextGen Healthcare, Inc. Reports Fiscal 2021 Second Quarter Results Exhibit 99.1 NextGen Healthcare, Inc. Reports Fiscal 2021 Second Quarter Results IRVINE, Calif.— Oct. 22, 2020 - NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, today announced its fiscal 2021 second quarter ended September 30, 2020 operating results. Fiscal 2021 Second Quarter Highlights Revenue for the fiscal 2021 second quarter
October 22, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
August 20, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commiss
August 20, 2020	EX-10.1	NextGen Healthcare, Inc, FY2021 Director Compensation Plan Exhibit 10.1 NextGen Healthcare, Inc. FY 2021 Director Compensation Plan Tier 0 Employee Director Tier 1 Non-Employee Director (Base) Tier 2 Nominating & Governance Committee Chairperson (Additional) Tier 3 Compensation Committee Chairperson (Additional) Tier 4 Audit Committee Chairperson (Additional) Tier 5 Board Vice Chairperson (Additional) Tier 6 Board Chairperson and Chairperson Emeritus (Add
August 5, 2020	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissio
August 5, 2020	DEFA14A	- DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy S
July 31, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commissio
July 31, 2020	EX-99.1	NextGen Healthcare, Inc. Reports Fiscal 2021 First Quarter Results Exhibit 99.1 NextGen Healthcare, Inc. Reports Fiscal 2021 First Quarter Results IRVINE, Calif.— July 30, 2020 - NextGen Healthcare, Inc. (Nasdaq: NXGN), the leading provider of ambulatory-focused healthcare technology solutions, announced today its fiscal 2021 first quarter ended June 30, 2020 operating results. Fiscal 2021 First Quarter Highlights Revenue for the fiscal 2021 first quarter was $13
July 31, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as s
July 10, 2020	DEFR14A	- DEFR14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definiti
July 7, 2020	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement
July 7, 2020	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement
June 1, 2020	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant as specifie
June 1, 2020	EX-21	List of subsidiaries. Exhibit 21 NEXTGEN HEALTHCARE, INC. LIST OF SUBSIDIARIES Name of Subsidiary State or Other Jurisdiction of Incorporation or Organization NextGen Healthcare Information Systems, LLC California NXGN Management LLC (f/k/a QSI Management LLC) California NextGen Cares Foundation, Inc. California NextGen RCM Services, LLC Missouri Topaz Information Systems, LLC Arizona Medfusion, Inc. North Carolina OTT
June 1, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
June 1, 2020	EX-99.1	NEXTGEN HEALTHCARE, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) Exhibit 99.1 FOR IMMEDIATE RELEASE June 1, 2020 NextGen Healthcare, Inc. Reports Fiscal 2020 Fourth Quarter and Year-End Results IRVINE, Calif. – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, announced today its fiscal 2020 fourth quarter and year end March 31, 2020 operating results. Fiscal 2020 Fourth Quarter and Year-End Highl
May 22, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
May 4, 2020	EX-99.1	NextGen Healthcare, Inc. Provides Business Update and Preliminary Unaudited Fiscal 2020 Fourth Quarter and Year-End Results Exhibit 99.1 FOR IMMEDIATE RELEASE May 4, 2020 NextGen Healthcare, Inc. Provides Business Update and Preliminary Unaudited Fiscal 2020 Fourth Quarter and Year-End Results IRVINE, Calif. – (BUSINESS WIRE) – NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, announced today a business update and preliminary unaudited fiscal 2020 fourth quarter and
May 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commission
April 10, 2020	SC 13G/A	NXGN / NextGen Healthcare, Inc. / Hussein Ahmed - SCHEDULE 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NextGen Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 65343C102 (CUSIP Number) Mary Ann Frantz Miller Nash Graham & Dunn LLP 111 S.W. Fifth Avenue, Suite 3400, Portland, Oregon 97204 (503)-224-5858 (Name, Address and Telep
February 14, 2020	SC 13G/A	NXGN / NextGen Healthcare, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 10)* Nextgen Healthcare, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 65343C102 (CUSIP Number) Eddie C. Brown Brown Capi
February 12, 2020	SC 13G/A	NXGN / NextGen Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: NextGen Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 65343C102 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed
January 31, 2020	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2019 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of I
January 31, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
January 24, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
January 23, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2020 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
January 23, 2020	EX-99.1	NEXTGEN HEALTHCARE, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) Exhibit 99.1 FOR IMMEDIATE RELEASE January 23, 2020 NextGen Healthcare, Inc. Reports Fiscal 2020 Third Quarter IRVINE, Calif. – (BUSINESS WIRE) – NextGen Healthcare, Inc. (NASDAQ: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, announced today its fiscal 2020 third quarter ended December 31, 2019 operating results. Fiscal 2020 Third Quarter Highlights On a GAAP bas
December 30, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2019 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commi
December 12, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2019 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
December 12, 2019	EX-99.1	NextGen Healthcare Completes Acquisition of Medfusion EX-99.1 Exhibit 99.1 NextGen Healthcare Completes Acquisition of Medfusion Irvine, Calif. – Dec. 9, 2019 – NextGen Healthcare, Inc. (NASDAQ: NXGN), a leading provider of ambulatory-focused technology solutions, today announced it has completed the acquisition of Medfusion, Inc. (“Medfusion”) a patient experience platform leader. “Patient experience drives patient engagement, which leads to better
November 18, 2019	EX-2.1	Agreement and Plan of Merger, dated November 12, 2019, by and among NextGen Healthcare, Inc., Renegade Merger Sub, Inc., MedFusion, Inc., and Project Renegade LLC, as the Equityholders Representative EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER dated as of November 12, 2019 by and among NEXTGEN HEALTHCARE, INC. (“Parent”), RENEGADE MERGER SUB, INC. (“Merger Sub”), MEDFUSION, INC. (the “Company”), and PROJECT RENEGADE LLC (the “Equityholders Representative”), and solely for purposes of Section 6.9 hereof GREENLIGHT HEALTH DATA SOLUTIONS, INC. (“Newco”) TABLE OF CONTENTS Page ARTICLE I. DEFIN
November 18, 2019	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2019 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commi
November 18, 2019	EX-99.1	NextGen Healthcare Announces Agreement to Acquire Medfusion, Inc. Leading Patient Experience Platform Advances Company’s Market Position EX-99.1 Exhibit 99.1 NextGen Healthcare Announces Agreement to Acquire Medfusion, Inc. Leading Patient Experience Platform Advances Company’s Market Position Irvine, Calif.— November 13, 2019 – NextGen Healthcare, Inc. (NASDAQ:NXGN) (“NextGen Healthcare” or “the Company”), a leading provider of ambulatory-focused technology solutions, today announced an agreement to acquire Medfusion, Inc. (“Medfu
October 24, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-12537 NEXTGEN HEALTHCARE, INC. (Exact name of registrant
October 23, 2019	S-8	NXGN / NextGen Healthcare, Inc. S-8 - - S-8 As filed with the Securities and Exchange Commission on October 23, 2019 Registration No.
October 23, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2019 NEXTGEN HEALTHCARE, INC. (Exact name of Registrant as Specified in Its Charter) California 001-12537 95-2888568 (State or Other Jurisdiction of Incorporation) (Commis
October 23, 2019	EX-99.1	NEXTGEN HEALTHCARE, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) Exhibit 99.1 FOR IMMEDIATE RELEASE October 23, 2019 NextGen Healthcare, Inc. Reports Fiscal 2020 Second Quarter IRVINE, Calif. – (BUSINESS WIRE) – NextGen Healthcare, Inc. (NASDAQ: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, announced today its fiscal 2020 second quarter ended September 30, 2019 operating results. Fiscal 2020 Second Quarter Highlights On a GAAP
September 17, 2019	SC 13G	NXGN / NextGen Healthcare, Inc. / Hussein Ahmed - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NextGen Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 65343C102 (CUSIP Number) Mary Ann Frantz, Miller Nash Graham & Dunn LLP 111 S.W. Fifth Avenue, Suite 3400, Portland, Oregon 97204 (503)-224-5858 (Name, Address an
September 12, 2019	SC 13D/A	NXGN / NextGen Healthcare, Inc. / Hussein Ahmed - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 15) NEXTGEN HEALTHCARE, INC. (Name of Issuer) Common Stock, $.01 Par Value (Title of Class of Securities) 65343C102 (CUSIP Number) Mary Ann Frantz Miller Nash Graham & Dunn LLP 111 S.W. Fifth Avenue, Suite 3400 Portland, Oregon 97204 Telephone: (503

NXGN / NextGen Healthcare Inc - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)